Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Last Name

Contact Us
If you have any questions or feedback please contact us.

Laurel Lawson Lenz Jr.

InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Immunology Microbiology

    Collapse Research 
    Collapse research activities and funding
    F32AI010481     (LENZ, LAUREL L)May 1, 2000
    Role: Principal Investigator

    R01AI055701     (LENZ, LAUREL L)Dec 1, 2004 - Nov 30, 2010
    CD8 Mediated Apoptosis During T Cell Development
    Role: Principal Investigator

    R01AI065638     (LENZ, LAUREL L)Jul 1, 2005 - Jan 31, 2017
    Active Subversion of Innate Immunity by Bacterial LysM Protein
    Role: Principal Investigator

    R56AI065638     (LENZ, LAUREL L)Aug 1, 2011 - Feb 14, 2012
    Active Subversion of Innate Immunity by Bacterial LysM Protein
    Role: Principal Investigator

    R21AI102264     (LENZ, LAUREL L)Jul 1, 2012 - Jun 30, 2014
    IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
    Role: Principal Investigator

    R21AI103782     (LENZ, LAUREL L)Apr 15, 2013 - Mar 31, 2015
    Non-canonical responses to IFNab in the suppression of macrophage immunity
    Role: Principal Investigator

    R33AI102264     (LENZ, LAUREL L)Aug 15, 2014 - Jul 31, 2017
    IFNGR Down Regulation as a Host Target for Therapy of Infectious Diseases
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Eshleman EM, Delgado C, Kearney SJ, Friedman RS, Lenz LL. Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection. PLoS Pathog. 2017 May; 13(5):e1006388. PMID: 28542482.
      View in: PubMed
    2. Smith C, Jalbert E, de Almeida V, Canniff J, Lenz LL, Mussi-Pinhata MM, Cohen RA, Yu Q, Amaral FR, Pinto J, Alarcon JO, Siberry G, Weinberg A. Altered Natural Killer Cell Function in HIV-Exposed Uninfected Infants. Front Immunol. 2017; 8:470. PMID: 28484464.
      View in: PubMed
    3. Clark SE, Filak HC, Guthrie BS, Schmidt RL, Jamieson A, Merkel P, Knight V, Cole CM, Raulet DH, Lenz LL. Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection. PLoS Pathog. 2016 Jun; 12(6):e1005708. PMID: 27295349; PMCID: PMC4905663.
    4. Mills CD, Lenz LL, Harris RA. A Breakthrough: Macrophage-Directed Cancer Immunotherapy. Cancer Res. 2016 Feb 01; 76(3):513-6. PMID: 26772756; PMCID: PMC4738030 [Available on 02/01/17].
    5. Mills CD, Lenz LL, Ley K. Macrophages at the fork in the road to health or disease. Front Immunol. 2015; 6:59. PMID: 25762997; PMCID: PMC4329822.
    6. Mills CD, Thomas AC, Lenz LL, Munder M. Macrophage: SHIP of Immunity. Front Immunol. 2014; 5:620. PMID: 25538705; PMCID: PMC4255611.
    7. Kedl RM, Wysocki LJ, Janssen WJ, Born WK, Rosenbaum MD, Granowski J, Kench JA, Fong DL, Switzer LA, Cruse M, Huang H, Jakubzick CV, Kosmider B, Takeda K, Stranova TJ, Klumm RC, Delgado C, Tummala S, De Langhe S, Cambier J, Haskins K, Lenz LL, Curran-Everett D. General parity between trio and pairwise breeding of laboratory mice in static caging. J Immunol. 2014 Nov 15; 193(10):4757-60. PMID: 25381356; PMCID: PMC4440340.
    8. Eshleman EM, Lenz LL. Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity. Front Immunol. 2014; 5:431. PMID: 25309533; PMCID: PMC4161047.
    9. Czaja CA, Merkel PA, Chan ED, Lenz LL, Wolf ML, Alam R, Frankel SK, Fischer A, Gogate S, Perez-Velez CM, Knight V. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-? autoantibody. Clin Infect Dis. 2014 Mar; 58(6):e115-8. PMID: 24336756; PMCID: PMC3935498.
    10. Schmidt R, Lenz LL. Biological DNA Sensor: The impact of Nucleic Acids on Diseases and Vaccinology, Ken Ishii and Choon Kit Tang, editors. Adjuvants Targeting the DNA Sensing Pathways – Cyclic-di-GMP and Other Cyclic-di-Nucleotides. 2013; 313-336.
    11. Kearney SJ, Delgado C, Eshleman EM, Hill KK, O'Connor BP, Lenz LL. Type I IFNs downregulate myeloid cell IFN-? receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription. J Immunol. 2013 Sep 15; 191(6):3384-92. PMID: 23935197; PMCID: PMC3777655.
    12. Kearney S, Delgado C, Lenz LL. Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections. Immunol Res. 2013 Mar; 55(1-3):187-200. PMID: 22983898; PMCID: PMC3926967.
    13. Schmidt RL, Lenz LL. Distinct licensing of IL-18 and IL-1ß secretion in response to NLRP3 inflammasome activation. PLoS One. 2012; 7(9):e45186. PMID: 23028835; PMCID: PMC3445464.
    14. Williams MA, Schmidt RL, Lenz LL. Early events regulating immunity and pathogenesis during Listeria monocytogenes infection. Trends Immunol. 2012 Oct; 33(10):488-95. PMID: 22677184; PMCID: PMC3440530.
    15. Cole C, Thomas S, Filak H, Henson PM, Lenz LL. Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes. Immunity. 2012 May 25; 36(5):807-20. PMID: 22542147; PMCID: PMC3361567.
    16. Rayamajhi M, Delgado C, Condon TV, Riches DW, Lenz LL. Lung B cells promote early pathogen dissemination and hasten death from inhalation anthrax. Mucosal Immunol. 2012 Jul; 5(4):444-54. PMID: 22472773.
      View in: PubMed
    17. Schmidt RL, Filak HC, Lemon JD, Potter TA, Lenz LL. A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells. PLoS Pathog. 2011 Nov; 7(11):e1002368. PMID: 22072975; PMCID: PMC3207947.
    18. Jin L, Hill KK, Filak H, Mogan J, Knowles H, Zhang B, Perraud AL, Cambier JC, Lenz LL. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP. J Immunol. 2011 Sep 01; 187(5):2595-601. PMID: 21813776; PMCID: PMC3159690.
    19. Knowles H, Heizer JW, Li Y, Chapman K, Ogden CA, Andreasen K, Shapland E, Kucera G, Mogan J, Humann J, Lenz LL, Morrison AD, Perraud AL. Transient Receptor Potential Melastatin 2 (TRPM2) ion channel is required for innate immunity against Listeria monocytogenes. Proc Natl Acad Sci U S A. 2011 Jul 12; 108(28):11578-83. PMID: 21709234; PMCID: PMC3136283.
    20. Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL. Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J Vis Exp. 2011 May 02; (51). PMID: 21587154; PMCID: PMC3280633.
    21. Boudreau JE, Stephenson KB, Wang F, Ashkar AA, Mossman KL, Lenz LL, Rosenthal KL, Bramson JL, Lichty BD, Wan Y. IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells. Cancer Res. 2011 Apr 01; 71(7):2497-506. PMID: 21307131.
      View in: PubMed
    22. Jin L, Lenz LL, Cambier JC. Cellular reactive oxygen species inhibit MPYS induction of IFNß. PLoS One. 2010 Dec 10; 5(12):e15142. PMID: 21170271; PMCID: PMC3000824.
    23. Rayamajhi M, Humann J, Kearney S, Hill KK, Lenz LL. Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence. 2010 Sep-Oct; 1(5):418-22. PMID: 21178482; PMCID: PMC2957886.
    24. Humann J, Lenz LL. Activation of naive NK cells in response to Listeria monocytogenes requires IL-18 and contact with infected dendritic cells. J Immunol. 2010 May 01; 184(9):5172-8. PMID: 20351186; PMCID: PMC2920760.
    25. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med. 2010 Feb 15; 207(2):327-37. PMID: 20123961; PMCID: PMC2822610.
    26. Lenz LL. CD5 sweetens lymphocyte responses. Proc Natl Acad Sci U S A. 2009 Feb 03; 106(5):1303-4. PMID: 19174525; PMCID: PMC2635820.
    27. Humann J, Lenz LL. Bacterial peptidoglycan degrading enzymes and their impact on host muropeptide detection. J Innate Immun. 2009; 1(2):88-97. PMID: 19319201.
      View in: PubMed
    28. Lenz LL. Encyclopedia of Pestilence, Pandemics, and Plagues, Joseph P. Byrne, editor. Immunology. 2008; 1:297-299.
    29. Lenz LL. Encyclopedia of Pestilence, Pandemics, and Plagues, Joseph P. Byrne, editor. Human Immunity and Resistance to Disease. 2008; 282-284.
    30. Lenz LL, Huang WA, Zhou C, Li Z, Calendar R. Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression. Clin Vaccine Immunol. 2008 Sep; 15(9):1414-9. PMID: 18650400; PMCID: PMC2546660.
    31. Lenz LL, Andrews-Polymenis HL. Silencing the alarm: insights into the interaction between host and pathogen. Conference on Microbial Pathogenesis: Mechanisms of Infectious Disease. EMBO Rep. 2008 Jan; 9(1):27-32. PMID: 18084188; PMCID: PMC2246619.
    32. Noor S, Goldfine H, Tucker DE, Suram S, Lenz LL, Akira S, Uematsu S, Girotti M, Bonventre JV, Breuel K, Williams DL, Leslie CC. Activation of cytosolic phospholipase A2alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2. J Biol Chem. 2008 Feb 22; 283(8):4744-55. PMID: 18083708; PMCID: PMC4741307.
    33. Humann J, Bjordahl R, Andreasen K, Lenz LL. Expression of the p60 autolysin enhances NK cell activation and is required for listeria monocytogenes expansion in IFN-gamma-responsive mice. J Immunol. 2007 Feb 15; 178(4):2407-14. PMID: 17277147.
      View in: PubMed
    34. Lenz LL. Everything you always wanted to know about NK cells but were afraid to ask, Laurent Brossay, Ed. NK cells and the innate response to intracellular bacterial infections. 2007; 147-166.
    35. Muraille E, Narni-Mancinelli E, Gounon P, Bassand D, Glaichenhaus N, Lenz LL, Lauvau G. Cytosolic expression of SecA2 is a prerequisite for long-term protective immunity. Cell Microbiol. 2007 Jun; 9(6):1445-54. PMID: 17244189.
      View in: PubMed
    36. Arrunategui-Correa V, Lenz L, Kim HS. CD1d-independent regulation of NKT cell migration and cytokine production upon Listeria monocytogenes infection. Cell Immunol. 2004 Nov-Dec; 232(1-2):38-48. PMID: 15922714.
      View in: PubMed
    37. Diehl GE, Yue HH, Hsieh K, Kuang AA, Ho M, Morici LA, Lenz LL, Cado D, Riley LW, Winoto A. TRAIL-R as a negative regulator of innate immune cell responses. Immunity. 2004 Dec; 21(6):877-89. PMID: 15589175.
      View in: PubMed
    38. Ploss A, Lauvau G, Contos B, Kerksiek KM, Guirnalda PD, Leiner I, Lenz LL, Bevan MJ, Pamer EG. Promiscuity of MHC class Ib-restricted T cell responses. J Immunol. 2003 Dec 01; 171(11):5948-55. PMID: 14634106; PMCID: PMC2791464.
    39. Lenz LL, Mohammadi S, Geissler A, Portnoy DA. SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12432-7. PMID: 14527997; PMCID: PMC218775.
    40. Lenz LL, Portnoy DA. Identification of a second Listeria secA gene associated with protein secretion and the rough phenotype. Mol Microbiol. 2002 Aug; 45(4):1043-56. PMID: 12180923.
      View in: PubMed
    41. Auerbuch V, Lenz LL, Portnoy DA. Development of a competitive index assay to evaluate the virulence of Listeria monocytogenes actA mutants during primary and secondary infection of mice. Infect Immun. 2001 Sep; 69(9):5953-7. PMID: 11500481; PMCID: PMC98721.
    42. Lenz LL, Butz EA, Bevan MJ. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med. 2000 Oct 16; 192(8):1135-42. PMID: 11034603; PMCID: PMC2195866.
    43. Princiotta MF, Lenz LL, Bevan MJ, Staerz UD. H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med. 1998 May 18; 187(10):1711-9. PMID: 9584149; PMCID: PMC2212287.
    44. Lenz LL, Bevan MJ. CTL responses to H2-M3-restricted Listeria epitopes. Immunol Rev. 1997 Aug; 158:115-21. PMID: 9314079.
      View in: PubMed
    45. Harty JT, Lenz LL, Bevan MJ. Primary and secondary immune responses to Listeria monocytogenes. Curr Opin Immunol. 1996 Aug; 8(4):526-30. PMID: 8794012; PMCID: PMC2784914.
    46. Lenz LL, Dere B, Bevan MJ. Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity. 1996 Jul; 5(1):63-72. PMID: 8758895; PMCID: PMC2778046.
    47. Lenz LL, Bevan MJ. H2-M3 restricted presentation of Listeria monocytogenes antigens. Immunol Rev. 1996 Jun; 151:107-21. PMID: 8872487.
      View in: PubMed
    48. Fattaey A, Lenz L, Consigli RA. Production and characterization of monoclonal antibodies to budgerigar fledgling disease virus major capsid protein VP. Avian Dis. 1992 Jul-Sep; 36(3):543-53. PMID: 1417586.
      View in: PubMed
    Lenz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description

    Copyright © 2017 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.10.0)